Tag: Disease

  • Vaccines for cancer, heart disease to be ready by end of decade

    Vaccines for cancer, heart disease to be ready by end of decade

    [ad_1]

    London: Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions including cancer, experts have said.

    A leading pharmaceutical firm said it is confident that jabs for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030, the Guardian reported.

    Studies into these vaccinations are also showing “tremendous promise”, with some researchers saying 15 years’ worth of progress has been “unspooled” in 12 to 18 months thanks to the success of the Covid jab.

    MS Education Academy

    Paul Burton, the chief medical officer of pharmaceutical company Moderna, said he believes the firm will be able to offer such treatments for “all sorts of disease areas” in as little as five years.

    The firm, which created a leading coronavirus vaccine, is developing cancer vaccines that target different tumour types, the Guardian reported.

    Burton said: “We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives. I think we will be able to offer personalised cancer vaccines against multiple different tumour types to people around the world.”

    He also said that multiple respiratory infections could be covered by a single injection — allowing vulnerable people to be protected against Covid, flu and respiratory syncytial virus (RSV) — while mRNA therapies could be available for rare diseases for which there are currently no drugs, the Guardian reported.

    Therapies based on mRNA work by teaching cells how to make a protein that triggers the body’s immune response against disease.

    [ad_2]
    #Vaccines #cancer #heart #disease #ready #decade

    ( With inputs from www.siasat.com )

  • Hyderabad: UoH contributes to research on Fatty Liver Disease

    Hyderabad: UoH contributes to research on Fatty Liver Disease

    [ad_1]

    A recent research study at the University of Hyderabad (UoH) provides another dimension to reduce fat accumulation in the liver. This reduces the onset of non-alcoholic fatty liver disease (NAFLD) and opens up new avenues for therapeutic intervention.

    The liver plays a central role in lipid metabolism. Fatty liver Disease (FLD) in particular the Non Alcoholic Fatty Liver Disease (NAFLD) is a serious health concern that affects 25% of the world’s population.

    It is characterised by increased abdominal fat accumulation and metabolic abnormalities including insulin resistance, type-2-diabetes mellitus, hypertension, dyslipidemia and cardiovascular problems. NAFLD can progress to hepatocellular carcinoma and liver failure.

    This study shows that Lipid associated mitochondria promotes fatty acid oxidation through distinct bioenergetics pattern in the liver.

    The study was conducted by professor Naresh Babu Sepuri, Department of Biochemistry, School of Life Sciences at UoH and his team. The main contributors for the study are Dr Noble Kumar Talari and Dr Ushodaya Mattam, Niroj Kumar, Arun Kumar P.

    It demonstrates the significance of functional segregation of mitochondria as any aberration in lipid droplet-associated mitochondria may lead to NAFLD.

    The study has been published as an article in Nature Communications, a peer reviewed journal.

    Subscribe us on The Siasat Daily - Google News

    [ad_2]
    #Hyderabad #UoH #contributes #research #Fatty #Liver #Disease

    ( With inputs from www.siasat.com )